BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1

Historical Holders from Q2 2021 to Q3 2025

CUSIP
09061GAK7
Type / Class
Debt / NOTE 1.250% 5/1
All holders as of June 30, 2025
Q2 2025
Total 13F principal, excl. options
538M
Holdings value
$508M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
66
Number of buys
26
Number of sells
-29
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1

Period Principal Value Change Price Investors
2025 Q3 $3.48M $3.32M -$2.52M $0.95 1
2025 Q2 $538M $508M +$82M $0.94 66
2025 Q1 $447M $422M -$3.97M $0.94 63
2024 Q4 $434M $404M +$16.7M $0.93 71
2024 Q3 $411M $392M -$44.1M $0.95 61
2024 Q2 $458M $439M -$26.4M $0.96 58
2024 Q1 $484M $480M +$12M $0.99 57
2023 Q4 $84.7M $87.4M $1.03 2
2023 Q3 $377M $375M +$15.1M $0.99 47
2023 Q2 $362M $366M +$30.2M $1.01 47
2023 Q1 $333M $347M +$77.6M $1.04 44
2022 Q4 $257M $283M +$42.3M $1.08 44
2022 Q3 $209M $177M -$103M $0.99 36
2022 Q2 $320M $282M -$9.9M $0.99 34
2022 Q1 $323M $295M +$130M $1.00 28
2021 Q4 $217M $195M -$31.4M $1.04 32
2021 Q3 $249M $436M +$2.61M $1.00 26
2021 Q2 $244M $247M +$247M $1.00 28